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Cytidine triphosphate synthase catalyzes the synthesis of cytidine 5′-triphosphate (CTP)
from uridine 5′-triphosphate (UTP), the final step in the production of cytidine nucleotides.
CTP synthases also form filamentous structures of different morphologies known as
cytoophidia, whose functions in most organisms are unknown. Here, we identified and
characterized a novel CTP synthase (TgCTPS) from Toxoplasma gondii. We show that
TgCTPS is capable of substituting for its counterparts in the otherwise lethal double
mutant (ura71 ura81) of Saccharomyces cerevisiae. Equally, recombinant TgCTPS
purified from Escherichia coli encodes for a functional protein in enzyme assays. The
epitope-tagged TgCTPS under the control of its endogenous promoter displays a
punctate cytosolic distribution, which undergoes spatial reorganization to form foci or
filament-like structures when the parasite switches from a nutrient-replete (intracellular)
to a nutrient-scarce (extracellular) condition. An analogous phenotype is observed upon
nutrient stress or after treatment with a glutamine analog, 6-diazo-5-oxo-L-norleucine
(DON). The exposure of parasites to DON disrupts the lytic cycle, and the TgCTPS is
refractory to a genetic deletion, suggesting an essential requirement of this enzyme for
T. gondii. Not least, this study, together with previous studies, supports that CTP synthase
can serve as a potent drug target, because the parasite, unlike human host cells, cannot
compensate for the lack of CTP synthase activity.
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INTRODUCTION
Toxoplasma gondii, the causative agent of Toxoplasmosis, affects approximately one third of
the world’s population. It is usually asymptomatic in healthy individuals, but can lead to severe
problems in the fetus and in immunocompromised or immunosuppressed patients, such as those
infected with HIV (Montoya and Liesenfeld, 2004). The current treatments against toxoplasmosis
display side effects and adverse reactions in many patients (Haverkos, 1987; Leport et al., 1988).
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In addition, studies show that the effectiveness of prenatal
treatment is uncertain (Gilbert, 2001). Thus, it is important to
seek new targets for drug design.
The de novo pyrimidine biosynthetic pathway in T. gondii
is a potential target for new drugs, because it is required for
the parasite’s virulence and survival (Fox and Bzik, 2002; Hyde,
2007). The rate limiting step in this pathway is catalyzed by
CTP synthase, which catalyzes the formation of CTP, an essential
biomolecule (Long et al., 1970; Endrizzi et al., 2005). CTP serves
as a building block for nucleotides and nucleic acids (Hatse et al.,
1999) and is required for protein glycosylation (Denecke and
Kranz, 2009). Moreover, it acts as a high energy molecule during
lipid biogenesis (Liu et al., 2004; Chang and Carman, 2008)
and participates in cellular communication processes (Sellmeier
et al., 2013). Indeed, it is a recognized potential target for
drug development to treat diseases such as cancer (Williams
et al., 1978; Verschuur et al., 1998; Hansel et al., 2003) and
infections caused by viruses (De Clercq, 2009), bacteria (Wylie
et al., 1996a,b; Mori et al., 2015), and parasites (Lim et al., 1996;
Hendriks et al., 1998; Hofer et al., 2001).
Recently, it has been shown that CTP synthase can form
filaments in a wide range of organisms, from prokaryotes
to eukaryotes, for example Caulobacter crescentus (Ingerson-
Mahar et al., 2010), Escherichia coli (Barry et al., 2014),
Schizosaccharomyces pombe (Ingerson-Mahar et al., 2010; Zhang
et al., 2014), Saccharomyces cerevisiae, Drosophila melanogaster,
D. virilis, D. pseudoobscura (Liu, 2010), Rattus norvegicus (Noree
et al., 2010) and mammalian cells (Carcamo et al., 2011). In
C. crescentus, the filaments play a cytoskeleton-like role in
maintaining the bacterium’s curved morphology, nevertheless, in
most organisms, their function remains unknown. The dynamics
of the formation of CTP synthase structures, designated as
cytoophidia (Greek cyto = cell and ophidia = serpents), rods and
rings (RR) structures, or CTPS structures, seem to be species-
specific. The process is regulated by nutrient deficit, intracellular
levels of nucleotides, progress of the cell cycle, and the presence
of inhibitors.
In mammalian cells, mainly in cancer cell lines, some RR
structures also contain inosine monophosphate dehydrogenase 2
(IMPDH2) as a major component (Carcamo et al., 2011). They
are strongly induced by treatment with either CTP synthase
inhibitors such as 6-diazo-5-oxo-L-norleucine (DON), acivicin
and 3′-deazauridine, or IMPDH2 inhibitors such as ribavirin
and mycophenolic acid (Ji et al., 2006; Carcamo et al., 2011;
Chen et al., 2011; Chang et al., 2015). Interestingly, most primary
cell lines present RR structures only under treatment with
CTP synthase or IMPDH2 inhibitors (Carcamo et al., 2011).
The RR structures are not associated with any other known
subcellular structure (Thomas et al., 2012), although they are
present in the nucleus as well as in the cytosol (Carcamo et al.,
2014).
This study identified and characterized the CTP synthase
from T. gondii (TgCTPS). Unlike mammals, T. gondii and other
parasites have a limited capacity to salvage pyrimidines, most
relevantly cytidine (Hofer et al., 2001; Yuan et al., 2005; Garavito
et al., 2015), therefore TgCTPS represents an excellent anti-
parasitic target.
RESULTS
TgCTPS Encodes an Active CTP Synthase
Our bioinformatic searches identified a single CTP synthase
gene in T. gondii (TGGT1_299210) that consists of 6 exons and
5 introns, and encodes a putative protein of 652 amino acids
(toxodb.org). The open reading frame was cloned, confirmed
by sequencing and submitted to GenBank (JN847214.1). The
predicted amino acid sequence of TgCTPS contained two
conserved domains, an N-terminal synthase domain (a P-loop
containing nucleoside triphosphate hydrolase) and a C-terminal
glutaminase domain with the conserved catalytic triad, Cys474—
His604—Glu606 of a type I amidotransferase (Massière and
Badet-Denisot, 1998) (Figure 1). TgCTPS contained a unique N-
terminal extension (57 amino acids), an insertion of 10 residues
from T330 to Gly339 that is not present in CTP synthases from
other organisms, and an insertion of 7 residues from A416 to
S423, adjacent to a helix found in the glutaminase domain of
eukaryotic CTP synthases (Lynch et al., 2017) (Supplementary
Figure 1).
To test whether the putative TgCTPS sequence encoded
an active enzyme, we performed a complementation assay
in S. cerevisiae SDO195. This yeast strain lacks the two
endogenous CTP synthases, and therefore requires the presence
of a plasmid expressing an active CTP synthase to grow
(Figure 2) (Ozier-Kalogeropoulos et al., 1994). The strain is
also deficient in LEU2 and URA3, enzymes of leucine and
pyrimidine biosynthesis, which makes it auxotrophic for leucine
and uracil, and consequently facilitates genetic manipulation.
SDO195 harbors a plasmid (ScCTPS1/URA3) expressing yeast
CTPS1 and URA3 to permit its selection on uracil-free media.
A plasmid shuffling approach was used to replace this plasmid
with another plasmid (TgCTPS/LEU2) expressing TgCTPS and
LEU2. Positive and negative controls were a plasmid expressing
ScCTPS1 (ScCTPS1/LEU2), and the empty vector, respectively.
First, SDO195 was transformed with TgCTPS/LEU2, and cells
were selected on plates containing synthetic complete (SC)
medium without leucine or uracil, or on SC medium without
leucine but containing uracil (Figure 2B). The colonies selected
in the latter medium contained both plasmids, TgCTPS/LEU2
and ScCTPS1/URA3, as confirmed by PCR (data not shown).
Next, to eliminate cells expressing ScCTPS1/URA3, we employed
a counter-selection strategy using 5′-fluoorotic acid (5′-FOA),
which is based on the capability of URA3-expressing cells to
metabolize this compound into a toxic uracil analog, leading
to cell death (Figure 2C). The loss of the ScCTPS1/URA3 was
confirmed by PCR (data not shown) and by auxotrophy for uracil
(Figure 2C). Unlike the negative control, the plasmid expressing
TgCTPS, as well as the positive control expressing ScCTPS1,
permitted growth of S. cerevisiae on the selective medium, which
confirmed that the parasite protein was functional, and capable
of substituting for the yeast protein in vivo.
The TgCTPS Gene Is Essential for Parasite
Survival
In T. gondii, de novo pyrimidine biosynthesis is a functional
and essential pathway (Fox and Bzik, 2002; Fox et al., 2011).
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FIGURE 1 | TgCTPS amino acid sequence. A consensus of secondary structure predictions is shown above the sequence. α- helices are highlighted in gray, strands
in orange, hairpins in light blue and coils in black. The conserved domains detected in the TgCTPS sequence are indicated by bars below the sequence. They include
a P-loop containing nucleoside triphosphate hydrolase domain at the N-terminus (green) and a class I glutamine amidotransferase domain at the C-terminus (yellow).
A palmitoylation site is predicted in the N-terminal extension. Cysteines 241 and 272, which form a disulphide bond, are depicted in light yellow. According to the
phosphoproteomic data from ToxoDB, three residues are phosphorylated in vivo in tachyzoites that are located in an insertion unique to TgCTPS. The catalytic triad
(Cys474-His604-Glu606) is indicated below the sequence in blue. Figure was generated using Geneiuos 9.1, available from http://www.geneious.com.
We used different strategies to produce a tachyzoite TgCTPS
mutant. The first strategy consisted of the destabilization of
TgCTPS expression by Cre-mediated displacement of its 3′-
UTR (Supplementary Figure 2A). Parasites (1ku80::DiCre)
(Andenmatten et al., 2013) were transfected with a construct
for 3′HA tagging of the TgCTPS gene and selected in medium
containing mycophenolic acid (MPA) and xanthine (XAN).
Unfortunately, transfected parasites did not survive when the
selection was applied. Transfection experiments were conducted
three times without any success, which indicated that TgCTPS
gene is regulated by its own 3′-UTR.
In a second approach, we attempted a swap of the endogenous
TgCTPS locus for a TgCTPS cDNA, which was flanked by
Cre-loxP sites and regulated by the TgCTPS−5′-UTR (1.5 kb)
and TgCTPS-3′-UTR (0.67 kb). A weak recombination-specific
amplification was observed in the pool of transfected parasites
(Supplementary Figure 2B), however, in individual clones, the
PCR identified only single crossover events at the 5′- or 3′-end,
indicating that the endogenous gene was retained in all cases.
We therefore decided to make a conditional mutant of
TgCTPS using a tetracycline-regulatable expression system.
The proper insertion of the drug-repressible TgCTPS-myc
ORF was tested by western blot, confirming the expression
of the full-length tagged protein (Supplementary Figure 2C).
The merodiploid strain (TgCTPSpTet/TgCTPS) grown with
anhydrotetracycline (ATc) for 40 h showed a decrease in the
expression of TgCTPS-c-myc (Supplementary Figure 2C). We
then designed the TgCTPS KO construct harboring CAT
selection marker (Kim et al., 1993). Parasites transfected
with TgCTPS_KO_CAT survived chloramphenicol selection
(Supplementary Figure 2C). Recombination-specific PCR to
assess the genomic integration showed that some of the isolated
clones were positive for 5’ crossover whereas others for 3’
crossover, but a mutant undergoing double crossover was never
observed (data not shown). Transfection experiments and PCR
screening were carried out at least three times, without observing
double crossovers. Taken together, these results indicate that
CTP synthase is tightly regulated and likely essential for parasite
survival. Likewise, out multiple attempts to delete the gene locus
by double homologous recombination were also unsuccessful,
suggesting an essential function of CTP synthase in T. gondii.
Purification of Active Recombinant
TgCTPS
We expressed full-length TgCTPS with a 6xHis tag at the
N-terminus in E. coli under standard culture conditions
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FIGURE 2 | Functional complementation of yeast CTP synthase double mutant by TgCTPS. (A) Schematic representation of the plasmid shuffling technique applied
to test TgCTPS function in vivo in S. cerevisiae. (B) The SDO195 strain was transformed with a LEU2 plasmid having the TgCTPS coding sequence. Resultant
transformants were plated on SC medium without leucine but containing uracil, and SC medium without uracil or leucine to select colonies carrying the two plasmids.
(C) A colony of each transformant, carrying two plasmids, was streaked out on SC −LEU +FOA and SC −LEU −URA +FOA media. ScCTPS1 was used as a positive
control and the empty vector was the negative control. Results are representative of three independent experiments.
(Supplementary Figure 3). Purification of this enzyme by cobalt-
affinity chromatography led to the recovery of a very small
amount (≤0.02mg per 1L cell culture) of active, soluble, full-
length TgCTPS, however with low purity (Supplementary Figure
3B). Altering the induction and purification conditions increased
the yield (Supplementary Figures 3C,D), but resulted in inactive
protein (data not shown). Therefore, we isolated TgCTPS
inclusion bodies from cell extract by centrifugation, solubilized
them in the presence of urea, and refolded by a matrix-assisted
method (Tsumoto et al., 2003; Dashivets et al., 2009), which
allowed us to recover active full-length refolded protein of
approximately 80% purity with a yield of 0.75 mg/L of cell culture
(Supplementary Figure 3E).
Dybas and coworkers performed a proteomic experiment
where membrane and cytosolic fractions of extracellular
tachyzoites were analyzed by mass spectrometry (Dybas et al.,
2008). Interestingly, two peptides of the unique N-terminus of
TgCTPS were found in the membrane fraction, while 17 peptides
from the rest of the TgCTPS sequence were found in the cytosolic
fraction (toxodb.org). In light of these data, we expressed a
version of 6xHis-TgCTPS lacking the first 57 residues, and
obtained a significant amount of active, soluble, truncated,
TgCTPS, which was ten-fold more soluble than the full-length
protein, at a yield of ≤ 0.2 mg/L cell culture (Supplementary
Figure 3F). The removal of this peptide increased the protein’s
solubility in E. coli without affecting the enzymatic activity
in vitro as described below.
Kinetic Characterization of TgCTPS
Activity
The synthesis of CTP by CTP synthase requires the substrates
ATP, UTP and glutamine. GTP participates in the reaction
as a positive effector (Lieberman, 1956; Levitzki and
Koshland, 1969). The kinetic parameters for the three
TgCTPS recombinant enzyme preparations are shown in
Figure 3 and Table 1. The UTP saturation curves produced
by all three showed similar sigmoidal behaviors (data not
shown) and kinetic parameters (Table 1), supporting the
idea that the refolding process did not significantly affect
the activity (Table 1) as reported for other CTP synthases
(Yuan et al., 2005). The full-length, refolded TgCTPS was
used for subsequent kinetic studies, because of its higher
yield.
The ATP saturation curve was fit to the Michaelis-Menten
equation (Figure 3A). However, the UTP saturation curve
exhibited sigmoidal behavior suggesting positive cooperativity,
which was confirmed by the shape of the curve in the double
reciprocal plot and by the Hill coefficient value > 1 (Figure 3B).
Positive cooperativity for UTP has been shown for other CTP
synthases, such as enzymes from E. coli, S. cerevisiae, Lactococcus
lactis, etc. (Long and Pardee, 1967; Yang et al., 1994; Nadkarni
et al., 1995; Wadskov-Hansen et al., 2001). The L-glutamine
saturation curve appeared to be hyperbolic, but the curve of
the double reciprocal plot was concave downward instead of
linear (Figure 3C), and the Hill coefficient was less than 1,
which indicated negative cooperativity in the binding of L-
glutamine to the active site (Levitzki and Koshland, 1972;
Segel, 1993). Negative cooperativity for L-glutamine has also
been described for EcCTPS (Levitzki and Koshland, 1972) and
ScCTP1S (Yang et al., 1994). The activity of TgCTPS depended
on GTP concentration, as observed for other CTP synthases
(Levitzki and Koshland, 1972; MacDonnell et al., 2004; Endrizzi
et al., 2005; Steeves and Bearne, 2011). We observed activation
at GTP <0.5mM, and inhibition at >0.5mM (Figure 3D).
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FIGURE 3 | Steady state kinetics of full-length refolded TgCTPS. (A) ATP saturation curve. Data were fitted to the Michaelis-Menten equation,
V=Vmax × [S]÷(Km+[S]). (B) UTP saturation curve. Parameters were calculated by fitting the data to the allosteric sigmoidal equation,
Y=Vmax × [S]
h
÷(Kh
0.5
+ [S]h ). (C) Glutamine saturation curve. Data were fitted to the Michaelis-Menten equation. (D) The effect of GTP on the
glutaminase-dependent TgCTPS activity. In panels (A-C), the insets show the corresponding double reciprocal plots.
The turnover number of TgCTPS was approximately three-fold
higher than that of EcCTP (Lunn and Bearne, 2004) and
approximately 160-fold higher than that of the HsCTPS (Chang
et al., 2007; Kassel et al., 2010). The catalytic efficiency, kcat/Km,
of TgCTPS was also higher than those observed for EcCTPS
and HsCTPS (Table 1) (Lunn and Bearne, 2004; Chang et al.,
2007; Kassel et al., 2010). The physiological concentrations of
ATP in tachyzoites range from ≈0.8 to 1.1mM (Pace et al.,
2011), suggesting a maximal rate of ≈70% for TgCTPS in vivo.
Our kinetic characterization of TgCTPS constitutes the first
step toward understanding the regulation of cytidine pools in
T. gondii.
We tested the effect of a glutamine analog DON, a known
inhibitor of CTP synthases, on TgCTPS full-length refolded
protein, and found an IC50 of ≈ 0.04µM (Supplementary
Figure 4). A concentration of 1µM DON completely
eliminated the measurable enzyme activity (Supplementary
Figure 4).
TgCTPS Forms Foci-Like Structures
Depending on Its Expression Levels and
the Parasitic Stage
To determine whether TgCTPS was able to form filament-like
structures in T. gondii tachyzoites, we generated an epitope-
tagged construct, and stable transgenic parasites expressing it
were selected for localization studies (Figure 4). This construct
allowed expression of a myc-tagged version of TgCTPS
under control of its own promoter region (pTgCTPS). The
resulting strain, RH TgCTPS_c-myc-HX, expressed the protein at
endogenous levels (Figure 4). Immunofluorescence experiments
showed TgCTPS formed foci-like structures in both intracellular
and extracellular parasites, although this pattern was more
pronounced in the latter (Figure 4). These results suggest that
the ability to form structures is conserved in TgCTPS, and the
frequency varies according to the infectious stage of the parasite.
We classified the TgCTPS structures observed as follows: foci
are approximately circular structures, small foci are <0.5µm in
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TABLE 1 | Kinetic parameters of CTP synthases from different organisms.
Organism Substrate Vmax
(U mg−1)
Km (mM) K0.5 (mM) kcat (s
−1) kcat / Km
(s−1 mM−1)
Reference
T. gondii (full length refolded)a L-Gln 24.0 ± 0.9 0.26 ± 0.04 29.6 114 This work
UTP 25.9 ± 0.9 0.47 ± 0.03
h = 1.60 ± 0.14
31.9 –
ATP 29.2 ± 0.9 0.54 ± 0.05 36 66.7
T. gondii (truncated) a UTP 31.3 ± 2.0 0.41 ± 0.06
h = 1.14 ± 0.15
38.6 104.3 This work
T. gondii (full length) a UTP 24.9 ± 3.0 0.41 ± 0.09
h = 1.40 ± 0.37
30.7 105.9 This work
E. coli L-Gln – 0.35 ± 0.06 – 6.1 17.8 ± 2.3 Lunn and Bearne, 2004;
MacLeod et al., 2006
UTP – − 0.28 ± 0.04
h = 1.26 ± 0.14
13.7 48.8
ATP – − 0.49 ± 0.02
h = 2.20 ± 0.12
12.8 25.9
S. cerevisiae (URA7) UTP 0.37 0.11 h = 1.4 – – Park et al., 2003
ATP 0.28 0.45 – –
Homo sapiens (CTP 1) L-Gln – 0.027 ± 0.009 – – – Chang et al., 2007; Kassel
et al., 2010
UTP – 0.59 ± 0.24 – ≈ 0.12 –
ATP – 0.17 ± 0.11 – - –
Homo sapiens (CTP 2) L-Gln – 0.1 ± 0.04 – - –
UTP – 0.19 ± 0.08 – – –
ATP – 0.06 ± 0.02 – – –
The values of TgCTPS kinetic constants were determined in triplicate and the averages are reported. The reported errors are standard deviations. One unit is defined as the conversion
of 1 µmol of substrate per minute at 37◦C.
aThe values were calculated with GraphPad Prism version 6.0e according to the best-fitted model.
diameter and large foci are >0.5µm in diameter; filament-like
structures are elongated structures, with 0.8 to 3µm length, and
0.2–0.5µm width.
The Glutamine Analog DON Alters
Localization of TgCTPS
To examine whether DON affects the dynamics of TgCTPS
localization, the RH TgCTPS_c-myc-HX strain was grown
in the presence of variable concentrations of DON ranging
from 2µM to 20µM. Changes in TgCTPS localization were
evaluated by IFA in intracellular (Figure 5A) and extracellular
parasites (Figure 5B). DON promoted the formation of TgCTPS
structures that began as simple foci in the cytosol (in absence or
at low concentrations of DON) and then assembled into large
foci, donuts or filament-like structures at high concentrations
of the drug (Figure 5). Quantification of this effect revealed
that approximately 30% of the extracellular parasites that
were cultured in the absence of DON exhibited large foci-
like structures, while intracellular parasites did not exhibit
these structures (Figures 6A,B). When parasites were treated
with 20µM DON more than 23% of the extracellular, and
approximately 13% of the intracellular parasites, exhibited large
filament-like structures, whose lengths ranged from >1 to
3µm (Figures 6C,D). Tachyzoites are approximately 6µm in
length and 2µm in diameter (Dubey et al., 1998), meaning
that the TgCTPS filament-like structures occupied up to half
the length of the parasite. In most cases, there was only one
TgCTPS filament-like structure per cell, usually oriented to
the apical end. In addition, parasites harboring a filament-like
structure also presented a small punctum, apparently localized
in the nucleus or between the nucleus and the posterior
end.
We concluded that DON stimulated TgCTPS assembly in
a concentration-dependent manner causing an increase in the
frequency of filament-like structure formation, as observed for
other eukaryotic CTP synthases (Carcamo et al., 2011; Chen et al.,
2011; Calise et al., 2014). The TgCTPS polymerization appears
to be promoted not only subsequent to the release of tachyzoites
from the host cell, but also upon inhibition of the CTP synthase
by DON.
DON Impairs the Lytic Cycle of T. gondii
The lytic cycle of T. gondii underlies the establishment of the
acute infection in vivo (Blader et al., 2015). To investigate whether
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 March 2018 | Volume 8 | Article 83
Narvaez-Ortiz et al. Characterization of the Toxoplasma gondii CTP Synthase
FIGURE 4 | The subcellular localization of TgCTPS in tachyzoites. TgCTPS expressed at endogenous levels. Immunostaining was performed using mouse anti-c-myc
(green) and rabbit anti-TgHsp90 (red) antibodies. Intracellular: HFF cells were infected with transfected parasites and fixed 27 hpi. Extracellular: Fresh extracellular
parasites were fixed. The TgCTPS punctate distribution is indicated by arrowheads (white). DIC: differential interference contrast. Scale bars: 5µm.
FIGURE 5 | DON concentration-dependent localization of TgCTPS in intracellular parasites (A) and extracellular parasites (B). (A) Immunofluorescence experiments
were performed with infected HFF cells cultured in the presence of variable concentrations of DON for 27 h. TgCTPS structures, such as larger foci and filament-like
structures, are indicated by arrowheads (white). Inset shows a zoom-in (3x magnified) for a TgCTPS filament-like structure (B) Immunofluorescence experiments were
performed with fresh extracellular parasites incubated for 6 h in variable concentrations of DON. Scale bars: 5µm.
DON exhibited an anti-parasitic activity, we performed plaque
assays, which recapitulate the successive rounds of lytic cycles
in vitro. Confluent monolayers of HFF cells were infected with
RH TgCTPS_c-myc-HX strain and grown in medium containing
variable concentrations of DON for 7 days, and then stained with
crystal violet. Plaques were identified as clear zones indicating
host cell lysis on a background of dye-stained host monolayer
(Figure 7A). We observed that the number and size of plaques
were significantly reduced in cultures treated with concentrations
≥5µM of DON (Figures 7B,C), which appeared to cause a
strong endodyogeny defect that prevented daughter cells to be
completely separated during cell division (Figure 7D). This was
also evident in the replication rates of the parasites cultured in
the presence of DON, where vacuoles contained only one, two
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FIGURE 6 | The formation of TgCTPS structures in the presence of DON or in nutrient depletion. (A,B) The percentage of parasites showing TgCTPS structures was
calculated based on the total number of cells for each condition. (A) Intracellular parasites were allowed to invade and replicate in medium containing DON for 27 h,
then IFAs were performed and TgCTPS structures were counted. The bars show the mean ± SD for three independent assays, each with at least 100 vacuoles
(B) Extracellular parasites were incubated in medium containing DON for 4–6 h. Three independent assays, each with at least 100 parasites, were evaluated; mean ±
SD. (C,D) Distribution of TgCTPS in the presence of DON. (C) Intracellular parasites grown in the presence of 20µM DON for 27 h. (D) Extracellular parasites
incubated in the presence of 20µM DON for 3 h. (E,F) The percentage of parasites showing TgCTPS structures was calculated based on the total number of cells for
each condition. (E) Intracellular parasites were allowed to invade and replicate in standard media (control), DMEM media without glutamine or in PBS, then IFAs were
performed and TgCTPS structures were counted. (F) Extracellular parasites were incubated in standard media (control), DMEM media without glutamine or in PBS for
4 h.
or four parasites, while vacuoles in control samples contained up
to 32 parasites (Figure 7D). Similar results were obtained when
experiments were carried out with tachyzoites of the parental
strain of T. gondii (data not shown). It is important to note
that approximately the same percentage of cells were infected in
absence or presence of DON, thus the inhibitor apparently did
not affect invasion.
DON treatment of cultures resulted in morphologically
altered parasites, referred to as “aberrant” parasites herein.
The loss of the typical rosette organization was observed
in intracellular parasites and the parasitophorous vacuole of
the aberrant parasites were amorphous with a large vacuolar
space (Figure 5A). In both intracellular and extracellular
parasites, aberrant morphology was remarkably prevalent
(Supplementary Figure 6A). Extracellular parasites were blunted
and spherical compared to the control (Supplementary Figure
6B). DON is not specific for CTP synthases, and can
inhibit other glutamine amidotransferases (Kisner et al.,
1980) (Supplementary Figure 7A). To test whether growth
impairment was due to DON inhibition of carbamoyl phosphate
synthase II, or GTP synthase, we compared the replication
rates of DON-treated cultures in the presence or absence
of uracil or guanine, respectively. Supplementation did not
significantly mitigate the effects of DON on the lytic cycle,
suggesting that TgCTPS is the primary target of the drug
(Supplementary Figure 7C).
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FIGURE 7 | Effect of DON in parasite propagation in culture. Plaque assay
showing a reduction in T. gondii proliferation in vitro in the presence of DON
(A–C). (A) Parasites were grown on human foreskin fibroblasts in the presence
or variable concentrations of DON for 7 days before fixation and staining with
crystal violet. Representatives of three independent experiments for each
concentration are shown. (B) The number of plaques observed in the
experiment from panel A. The percentage was calculated based on total
number of plaques observed in the control. (C) Sizes of plaques in mm2.
Replication assay under DON treatment (D) The rate of intracellular growth
was monitored 27 h after infection by counting the number of parasites per
vacuole. Significant differences were estimated by one-way ANOVA and
Dunnett’s test, ****P < 0.0001; mean ± SD (n = 3).
DISCUSSION
Nucleotide metabolism is energetically costly and usually tightly
controlled (Berg et al., 2002). CTP synthase is regulated at the
transcriptional level (Wylie et al., 1996a; Meng and Switzer,
2001; Jørgensen et al., 2003), allosterically at the enzymatic
level (Willemoes and Larsen, 2003; MacDonnell et al., 2004;
Endrizzi et al., 2005; Willemoes et al., 2005), and by post-
translational modifications (Park et al., 2003; Chang et al., 2007;
Choi and Carman, 2007; Kassel et al., 2010). The assembly
of CTP synthase into cytoophidia has been proposed to be an
additional mechanism of regulation, in which the enzymatic
activity is controlled by storing the protein in polymers composed
of inactive or less active protein in E. coli, S. cerevisiae and
Drosophila (Aughey et al., 2014; Barry et al., 2014; Noree et al.,
2014). Nevertheless, filaments containing active CTP synthase
have also been proposed for Drosophila (Strochlic et al., 2014).
Recently, Lynch et al. (2017) used cryoelectron microscopy
and X-ray crystallography to show that the conformation of
E. coli CTP synthase in filaments have reduced affinity for
substrates. In contrast, they found a different architecture for
filaments composed of human CTP synthase 1, where the protein
was present in an active conformation (Lynch et al., 2017).
Although TgCTPS is highly expressed in extracellular as well
as in intracellular tachyzoites, our data show that filament-
like structure occur in a stage-dependent manner in T. gondii.
We hypothesize that when the parasite is outside the host cell,
it requires a low CTPS activity, likely regulated by protein
assembly into filaments acting as the transient enzyme storage.
In contrast, intracellular parasites replicating within vacuoles
should require a congruently high CTPS activity to satisfy the
nucleotide and lipid biogenesis. This is plausibly controlled by the
release of CTPS from filament-like structures. Our future work
will involve the live imaging to follow dynamic changes in the
spatial expression of TgCTPS during the invasion and egress of
tachyzoites.
The dynamics of CTP synthase filament in organisms where
it has been studied appears to be affected by the cell cycle,
nutrient deprivation, all four nucleotides, and enzyme inhibitors.
Glucose deprivation induces CTPS filament formation in yeast
(Noree et al., 2010), while in mammalian cells filaments are
assembled in response to deprivation of glutamine (Calise et al.,
2014; Gou et al., 2014). In mammalian cells, high levels of GTP,
but not CTP, are critical for disassembling the RR structures
(Calise et al., 2014). In contrast, high levels of CTP stimulate the
filament assembly in E. coli and S. cerevisiae (Noree et al., 2010,
2014; Barry et al., 2014). In the latter case, CTPS filaments are
depolymerized by addition of ATP and UTP (Barry et al., 2014).
Thus, CTP synthase might serve as a sensor of carbon sources
(glucose and/or glutamine) and for the pools of each nucleotide
triphosphate (Noree et al., 2010). In the case of TgCTPS,
limitation of glutamine resulted in an increase in filament-like
structures, which was accentuated when extracellular parasites
were incubated just in PBS (Figures 6E,F). It is interesting to note
that glucose and glutamine serve as two major sources of carbon
for the parasite (Blume et al., 2009; Nitzsche et al., 2016, 2017).
Further experiments involving the parasite mutants defective
in glucose and glutamine catabolism are required to determine
whether the increase in CTPS structures is indeed related to the
sensing of these nutrients.
DON inhibits the CTPS activity by binding to its glutaminase
domain (Dion et al., 1956; Long et al., 1970). It has been studied
as an anticancer drug in several Phase II clinical trials in the
1980s, because tumor cells are more susceptible to the glutamine
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analogs compared to normal cells. Its therapeutic usage has been
abandoned due its tendency to cause nausea (Cervantes-Madrid
et al., 2015), but the drug provides an excellent tool to gain the
mechanistic insights of CTPS. The inhibitor has divergent effects
on the localization of different CTPS enzymes. In CcCTPS and
EcCTPS, filaments are disrupted when cells are treated with DON
(Ingerson-Mahar et al., 2010; Barry et al., 2014). In contrast,
DON promotes the formation of CTPS filaments in Drosophila
and human cells (Carcamo et al., 2011, 2014; Chen et al., 2011),
which is consistent with our observations in T. gondii. Analogs
of glutamine such as azaserine, acivicin and DON exhibit strong
anti-parasitic activities against Plasmodium, Trypanosoma and
Toxoplasma (Jaffe, 1963; Hofer et al., 2001; Fox and Bzik, 2003;
Fijolek et al., 2007; Nitzsche et al., 2016). We found that DON
at concentrations above 5µM caused a significant decrease in
the parasite yield. Tachyzoites treated with DON were aberrantly
shaped and apparently defective in endodyogeny. These results
together signify a potential therapeutic repurposing of this drug
to treat toxoplasmosis.
Two possible scenarios could explain the relationship of
CTPS to morphological alterations observed in intracellular and
extracellular parasites. In one scenario, a decrease of TgCTPS
activity would disrupt the membrane biogenesis because CTP
is needed to form phospholipid precursors, such as CDP-
diacylglycerol, CDP-ethanolamine and CDP-choline (Gupta
et al., 2005; Sampels et al., 2012; Hartmann et al., 2014). Gupta
and co-workers observed that an analog of choline interferes
with the synthesis of phosphatidylcholine, the most abundant
glycerophospholipid in the parasite. It results in a dramatic
effect on growth and membrane composition concurrent with
an aberrant morphology (Gupta et al., 2005). Likewise, genetic
ablation of CDP-DAG synthesis exerts a detrimental effect on
growth and virulence of T. gondii tachyzoites (Kong et al.,
2017). In an alternative scenario, the ability of TgCTPS to form
filament-like structures and the inhibitory effect of DON on the
parasite replication suggest that this protein could somehow be
associated with the inner membrane complex (IMC) or with
other component(s) of the parasite pellicle, the structure involved
in maintaining the parasite shape. This would be consistent
with a cytoskeleton-like function of CTP synthase filaments
observed in some bacteria (Ingerson-Mahar et al., 2010; Liu,
2016). Our prospective work involves further characterization of
filament-like structures by site-directedmutagenesis and electron
microscopy to discern the mechanistic roles of CTPS structures.
T. gondii and other related parasites (Lim et al., 1996; Hofer
et al., 2001; Yuan et al., 2005) express a single CTP synthase,
in contrast to eukaryotes, such as S. cerevisiae (Nadkarni et al.,
1995) and mammals (van Kuilenburg et al., 2000), which have at
least two different CTP synthase isoforms. TgCTPS is expressed
in all of the three archetypal T. gondii lineages (type I, type II
and type III strains) as well as in the parasite’s primary life cycle
stages, bradyzoites, tachyzoites and sporulated oocysts (Fritz
et al., 2012). TgCTPS activity is therefore likely to be important
for acute and chronic infections.
In mammalian cells, CTP is obtained primarily through
salvage of uridine and cytidine by uridine/cytidine kinase. In
cancer cells, where the proliferation rate is increased compared
to normal cells, CTP is obtained mostly via CTP synthase
(van den Berg et al., 1994, 1995). In contrast, T. gondii has
a limited pyrimidine salvage capacity especially for cytidine
(Figure 8). Uridine/cytidine kinase expression levels are low
in tachyzoites and enzymatic activity has not been detected
(Pfefferkorn, 1978; Fox et al., 1999). Furthermore, pyrimidine
phosphorylase, another salvage enzyme, was unable to use
cytidine as a substrate (Iltzsch, 1993). The parasite’s inability
to salvage CTP to compensate for the inhibition or absence
of TgCTPS, supports the notion that this is an essential gene
for parasite survival. Lourido and coworkers have adapted
CRISPR/Cas9 technology and developed a mathematical model
to determine the contribution of targeted genes to cell fitness in
FIGURE 8 | Pyrimidine salvage and interconversion reactions in T. gondii. The numbers next to the arrows represent the enzymes involved in each reaction, which are
listed in the table. The dotted red lines show conversions that probably do not take place in tachyzoites, for the reasons given in the table (l.e.: very low expression in
tachyzoites, n.d.: no activity detected, n.p.: no proteomic evidence). Data were extracted from: 1ToxoDB (www.toxodb.org, released 29); 2(Iltzsch, 1993); 3(Fox et al.,
1999); 4(Fox and Bzik, 2010); 5(Pfefferkorn, 1978). a One of these genes should belong to purine metabolism. CMP, cytidine 5′-monophosphate; CDP, cytidine
5′-diphosphate; CTP, cytidine 5′-triphosphate; d-, deoxy-; UMP, uridine 5′-monophosphate; UDP, uridine 5′-diphosphate; UTP, uridine 5′-triphosphate.
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T. gondii (Sidik et al., 2016). According to this model, genes are
assigned values reflecting their contribution to parasite fitness.
The maximum value for a non-essential gene is 2.96 and the
minimum value for an essential gene is −6.89. TgCTPS gene
has a mean fitness score of −5.67 (Sidik et al., 2016) confirming
our results that TgCTPS is refractory to a genetic deletion. The
physiologically essential nature of TgCTPS could be exploited to
design specific inhibitors of the parasite growth.
MATERIALS AND METHODS
Chemical and Biological Reagents
Reagents were purchased from Sigma-Aldrich unless noted
otherwise. Restriction endonucleases, T4 ligase and calf intestinal
alkaline phosphatase were from New England Biolabs. RNA was
isolated using the Pure Link RNA Mini kit from Ambion and
transcribed into first-strand cDNA using SuperScript III first-
strand cDNA synthesis kit (Invitrogen). Phusion high-fidelity
polymerase, dNTPs, DreamTaq DNA polymerase, GeneRuler
DNA ladders, PageRuler plus prestained protein ladder, HisPur
cobalt resin and the enhanced chemiluminescence (ECL)
system for western blot were from Thermo Scientific. All
oligonucleotides used in this study are listed in Supplementary
Table 1 and were synthetized by IDT or LifeTechnologies
(Invitrogen). Reagents for cell culture were from Biowest. The
pG140 and pG152 vectors were provided by Markus Meissner
(University of Glasgow, UK). The following primary antibodies
were used in western blot or immunofluorescence assays: mouse
or rabbit anti c-myc (monoclonal antibodies, M4439 and C3956,
Sigma), anti-PentaHis antibody (Qiagen), rabbit anti-TgHsp90
(Echeverria et al., 2010) kindly provided by Sergio Angel
(National University of SanMartín, Argentina) and anti-TgDHO
(Robles Lopez et al., 2006).
Toxoplasma and Host Cell Culture
All transgenic and mutant parasite lines are derivatives of the
RH parental strain. The1ku80-hxgprt− (Huynh and Carruthers,
2009), 1ku80-TaTi (Sheiner et al., 2011) and 1ku80::DiCre
(Andenmatten et al., 2013) strains were employed for genetic
manipulation of the TgCTPS gene and were kindly provided by
Vern Carruthers (University of Michigan, USA), Boris Striepen
(University of Georgia, USA) and Markus Meissner (University
of Glasgow, UK), respectively. Tachyzoites from all strains
were propagated in vitro by serial passages in human foreskin
fibroblasts (HFF) host cells, as previously described (Jacot et al.,
2014). Briefly, parasites were routinely cultured on confluent
HFF cell monolayers at a multiplicity of infection (MOI) of
3, until their complete lysis. Uninfected and infected cells
were maintained in a humidified incubator (37◦C, 5% CO2) in
D10 complete medium (DMEM supplemented with 10% FBS,
2mM L-glutamine, 1x MEM non-essential amino acids and 100
units mL−1 penicillin, and 100 µg mL−1 streptomycin). When
extracellular parasites were required, they were mechanically
released from the infected host cells and isolated by filtration
through 3µm filters (Nucleopore), followed by centrifugation
(400× g, 10min, RT).
Cloning, Expression and Purification of
TgCTPS
A cDNA Lambda Zap II library of T. gondii strain RH
tachyzoites was obtained from the AIDS Research and Reference
Reagent Program (catalog No. 1896). A phage containing
the putative TgCTPS sequence was isolated by PCR using
the method of Israel (Israel, 1993), which was packed
as a phagemid and subsequently used as a template to
amplify the TgCTPS coding sequence using Phusion high-
fidelity polymerase and ORF-specific primers (Supplementary
Table 1). The ORF of TgCTPS was cloned into pGEM T-
Easy vector (Promega) and subcloned into pET19b vector
(Novagen). Alternatively, cDNA template for amplification was
produced from RNA extracted from 5 × 106 fresh extracellular
tachyzoites using the RNeasy mini kit (Qiagen). A truncated
version of TgCTPS lacking the first 57 residues from its N-
terminus (6xHis-TgCTPS-truncated) was cloned in the pET15b
vector (Novagen). The recombinant proteins were expressed
in the E. coli BL21-CodonPlus(DE3)RP strain. Expression
conditions, purification and refolding of insoluble TgCTPS by
matrix assisted method are described in the Supplementary
Material.
Enzyme Assays
TgCTPS activity was determined by a pyruvate kinase/lactate
dehydrogenase-coupled assay (Morrical et al., 1986) in a
Multiskan GO spectrophotometer (Thermo Scientific).
Assay parameters were fitted with the SkanItT M software.
The standard assay mixture consisted of 70mM HEPES
pH 8.0, 12mM MgCl2, 1mM dithiothreitol, 2mM
phosphoenolpyruvate, 0.3mM NADH, 2U of pre-mixed
pyruvate kinase and lactate dehydrogenase (P0294, Sigma),
36.5 nM of purified TgCTPS, 0.4mM GTP, 1mM UTP, 1mM
ATP and 4mM glutamine in a total volume of 100 µL in a
96-well plate.
Ionic strength was adjusted to 0.2M in all experiments
using KCl. The TgCTPS recombinant protein activity was
measured by monitoring NADH reduction at 340 nm for
10min at 37◦C. To determine TgCTPS kinetic constants, one
substrate concentration was varied: L-glutamine (0–4mM), UTP
(0–3mM), or ATP (0–3mM), while other substrates were
maintained at saturating concentrations (highest concentration
in the range indicated). The effect of the allosteric activator
GTP on glutamine-dependent TgCTPS activity was evaluated
using variable concentrations of GTP. The initial velocities for
L-glutamine-dependent TgCTPS activity were determined, fitted
to the following equation (MacDonnell et al., 2004) and plotted
(Figure 3D).
vi
[E]T
=
k0 +
kact[GTP]
KA
1+ [GTP]KA +
[
[GTP]
Ki
]n
The values of the equation parameters were: k0, 1.73 s−1; kact,
14.98 s−1; KA, 0.25M; K i, 0.57M and n = 4.69. TgCTPS
activity was linear with reaction time and dependent on
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enzyme concentration (data not shown). Kinetic parameters were
determined using GraphPad Prism v6e software.
The inhibitory activity of DON was evaluated using fixed
saturating concentrations of the substrates ATP (2mM), UTP
(2mM), L-glutamine (4mM) and GTP (0.3mM), with varying
inhibitor concentrations. The percentage of TgCTPS activity
retained in each DON concentration was fitted to the following
equation and plotted using GraphPad Prism v6e software.
Y =
100
(1+ 10(LogIC50−X)∗HillSlope)
Immunoblot and Immunofluorescense
Assays
SDS-PAGE and western blot analysis were performed using
standard protocols (Sambrook and Russell, 2001). Briefly,
proteins were separated on 12% sodium dodecyl sulfate
polyacrylamide gels (SDS-PAGE) and transferred onto a
nitrocellulose membrane by semi-dry transfer. Membranes
were blocked in 5% non-fat milk in tris-buffered saline
(TBS), 0.2% Tween, incubated with an appropriate dilution
of primary antibodies (α-c-myc 1:1000, α-5XHis 1:1000 and
α-TgHsp90 1:500 in blocking solution) followed by secondary
antibodies conjugated to horseradish peroxidase (HRP) and
detected using the ECL chemiluminescence system (GE
Healthcare). Stripping of the membrane was performed
using the western blot recycling kit (Alpha diagnostics
international).
For IFA, confluent HFFs cells were grown on round
glass coverslips within 24-well plates and then infected with
T. gondii tachyzoites of the indicated strains at MOI of 1.
After 25–30 h of incubation, the medium was removed, and
the infected cells were washed twice with 1x PBS. Fixation was
performed with 4% paraformaldehyde (PFA) for 10min followed
by a neutralization step in 0.1M glycine/1x PBS for 5min.
Subsequently, cells were permeabilized in 0.2% Triton-X100/1x
PBS for 20min, followed by blocking (2–5% bovine serum
albumin in 0.2% Triton-X100/1x PBS) for 30min. The coverslips
were incubated for 1 h in the primary antibody solution and
washed 3 times for 5min each in 0.2% Triton-X100/1x PBS.
Afterwards, treatment with appropriate secondary antibodies
diluted (1:3,000) (Alexa-Fluor 488/Alexa-Fluor 594 conjugated
goat anti-mouse or anti-rabbit, Invitrogen) in blocking solution
was performed for 45–60min in the dark. Samples were
mounted with DAPI-Fluoromount G (SouthernBiotech) on
glass slides. Fluorescent imaging was performed using either
an ApoTome Imager.Z2 microscope (Carl-Zeiss, Germany) or
an Olympus FluoViewTM FV1000 unit with IX71 motorized
inverted microscope (Olympus, USA).
Functional Expression of TgCTPS in
S. cerevisiae
We performed a complementation assay using S. cerevisiae
SDO195 strain, kindly provided by Dr. George M. Carman
from the Rutgers University, New Jersey (Ozier-Kalogeropoulos
et al., 1994). The strain SDO195 lacks the two endogenous CTPS
genes, ura7 and ura8, encoding for ScCTPS1 and ScCTPS2,
respectively (Ostrander et al., 1998; Park et al., 2003; Han
et al., 2005; Chang et al., 2007). Because ura7 and ura8 are
synthetic lethal, the growth of this strain requires the presence
of a plasmid expressing a functional CTPS. In addition, it lacks
beta-isopropylmalate dehydrogenase (LEU2) that catalyzes the
third step in leucine biosynthesis, as well as OMP decarboxylase
(URA3) catalyzing the sixth step in pyrimidine biosynthesis.
The absence of LEU2 and URA3 permits the selection of
transgenic strains in leucine- or uracil-free media. The SDO195
strain can grow as it harbors the plasmid pYeLac-ScCTP1
along with URA3 as a selection marker (Ozier-Kalogeropoulos
et al., 1994). The replacement of this plasmid with a plasmid
expressing TgCTPS (plasmid shuffling) was done in two steps,
as described previously (Han et al., 2005). In the first step,
the TgCTPS coding sequence was amplified from the first-
strand cDNA prepared from the tachyzoite mRNA and cloned
into the pNEV-N-Leu vector (Sauer and Stolz, 1994) at the
NotI site, which allowed the expression of TgCTPS under the
control of the S. cerevisiae ATP synthase promoter (pPMA1)
(Sauer and Stolz, 1994). The SDO195 mutant was transformed
with 500 ng of pNEV-N_TgCTPS by the lithium acetate/single-
stranded carrier DNA/polyethylene glycol protocol (Gietz and
Woods, 2002). Additionally, we constructed a positive control
plasmid, pNEV-N_ScCTPS1. The empty vector was used as a
negative control. Transformants were selected on plates with SC
medium without leucine or uracil (Figure 2B, left). The eventual
yeast strain did not require uracil for growth because they still
contained ScCTPS1/URA3 (Figure 2B, right). In the second step,
counter-selection was performed in leuchine-free SC medium
containing 1% of 5′-FOA with incubation at 30◦C for 3–4 days
(Figure 2C). The procedure eliminated the yeast population
harboring ScCTPS1/URA3 because expression of URA3 allowed
5′-FOA to be metabolized into a toxic uracil analog, which is
incorporated into RNA, thereby causing death. The presence
of yeast cells expressing only TgCTPS/LEU2 was confirmed by
growth without leucine in the presence of 5′-FOA (Figure 2C,
left). These cells were auxotrophic for uracil (Figure 2C, right),
since the absence of pyrimidine biosynthesis is compensated by
uracil salvage.
Expression of Epitope-Tagged TgCTPS
Protein
The coding sequence of TgCTPS with a c-myc tag was
amplified using Pfu Ultra II fusion HS DNA polymerase
(Agilent technologies) using template cDNA extracted from
tachyzoites. The PCR product was digested and cloned into
the pTgGRA2-UPKO vector using NsiI and PacI sites, which
allowed a targeted insertion of TgCTPS-c-myc at the TgUPRT
locus (Donald and Roos, 1995). The pTgGRA2-UPKO-TgCTPS
construct was transformed into XL1-blue E. coli competent
cells and confirmed by PCR and sequencing. The linearized
construct (ApaI) was transfected into ≈10 × 106 fresh 1ku80-
TaTi tachyzoites suspended in Cytomix (10mM K2HPO4
/KH2PO4 pH 7.6, 25mM HEPES, 120mM KCl, 5mM MgCl2,
0.15mM CaCl2, 2mM EGTA, 5mM GSH, 5mM ATP) using
the Amaxa Nucleofector device (Lonza). Transfected parasites
were selected by resistance to 5-fluoro-2′-deoxyuridine (FUDR),
as described elsewhere (Donald and Roos, 1995). Parasites
expressing an ectopic copy of TgCTPS-c-myc protein were
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used for further localization experiments. For endogenous
expression of TgCTPS, gDNA was extracted from tachyzoites
to amplify a 1.2 kb fragment of the 3′-end of the TgCTPS
gene. As in the first construct, the reverse primer included
the c-myc tag. The PCR product was digested and ligated
into pTKO-HXGPRT vector via XcmI and EcoRI digestion. The
pTKO-HX-TgCTPS-myc plasmid was confirmed by sequencing.
The construct (10–15 µg) was linearized by SgrAI digestion
and used to transfect tachyzoites of the T. gondii 1ku80-
hxgprt− strain. The transfected parasites were added to the HFF
monolayer cells without selection for 10–24 h. Afterwards, the
standard culture medium was replaced by medium containing
25 µg mL−1 mycophenolic acid (MPA) and 50 µg mL−1
xanthine (XA) for selecting stable, transgenic parasites expressing
HXGPRT (Donald et al., 1996). A clonal stable parasite
line was isolated by limiting dilution in 96-well plates. The
1ku80-hxgprt−/TgCTPSc-myc/HXGPRT (referred to here as
RH TgCTPS_c-myc-HX) transgenic parasite line was used for
localization experiments and treatments with DON (D2141
Sigma).
Replication and Plaque Assays
Replication assays were performed to evaluate the ability of
T. gondii tachyzoites to reproduce intracellularly. Confluent
HFFs cells were grown on round glass coverslips within 24-
well plates and infected with fresh parasites at a MOI of 1.
IFAs were performed 27–54 hpi (hours post-infection) using
and anti-TgHsp90 (1:500, rabbit, Abcam) or anti-TgDHO (1:800,
rabbit, Strategic Biosolutions) antibodies, as described above.
Three independent biological experiments were performed and
the replication rates under different conditions were compared.
For each assay, the number of parasites per vacuole was counted
for around 100 vacuoles. Plaque assays were used to assess the
overall growth fitness of the parasite strain under indicated
conditions (Black and Boothroyd, 2000). HFF cell monolayers
in 6-well plates were inoculated with 250–350 parasites. Plates
were incubated without perturbation under indicated growth
conditions. After 7 days, cells were washed with 1x PBS followed
by fixation using methanol (precooled at −80◦C) for 2min
and stained with crystal violet for 10min. Three independent
biological replicates were done to calculate the mean number
and area of at least 50 plaques under each condition. The
number of plaques is presented as a percentage value of non-
treated parasites normalized to 100%. Plaques were imaged
and analyzed using the ImageJ software (National Institute of
Health, USA).
DON Treatment
6-diazo-5-oxo-L-norleucine (DON) (D2141, Sigma) was
solubilized at 30mM in pure water. Working dilutions for cell
culture were made in DMEM from the stock solution. The
concentration of DON was determined spectrophotometrically
using the molar extinction coefficient at 274 nm (ε1%1 cm = 683)
(Dion et al., 1956).
Parasites expressing TgCTPS at endogenous levels (RH
TgCTPS_c-myc-HX strain) were allowed to infect confluent
HFF cells in the presence of variable concentrations of DON
ranging from 2 to 20µM during 6–54 h at 37◦C. Extracellular
parasites were treated with variable concentrations of DON
(2–20µM) in complete medium for 3–6 h at 37◦C. The effect
of DON in the TgCTPS polymerization in intracellular and
extracellular parasites was evaluated by IFA, while its effect
on parasite fitness was evaluated by replication and plaque
assays. We observed no apparent effect on HFF cells cultured in
20µMDON.
Genetic Manipulation at the TgCTPS Locus
For the gene knockdown, a fragment of 1.2 kb of the 3′-end
of the TgCTPS genomic sequence was amplified and cloned
into the pG152 vector by ligation independent cloning (Stols
et al., 2002). Linearized plasmid (XhoI, 10–15 µg) was used to
transfect tachyzoites from the 1ku80::DiCre strain. Transgenic
parasites were selected for HXGPRT expression as described
above. The attempt to generate a conditional mutant by Cre
recombinase activity was performed using a gene-swap strategy
(Andenmatten et al., 2013). The construct was generated in
three sequential steps as follows: the TgCTPS 5′-UTR (1.5 kb)
and 3’UTR (1 kb) were amplified from T. gondii gDNA and
inserted into the p5RT70loxP-KillerRedloxP-YFP-HXGPRT
plasmid (Andenmatten et al., 2013) between ApaI and SacI
sites, respectively. The TgCTPS ORF plus a c-myc tag was
amplified from T. gondii cDNA, digested with MfeI and PacI
and cloned into the vector using EcoRI and PacI restriction
sites to replace the killerRed ORF. The resulting TgCTP5′UTR-
p5RT70–loxPTgCTPloxP-YFP-HXGPRT-TgCTP3′UTR vector
was linearized via ScaI and transfected into 1ku80::DiCre
recipient strain. Transgenic parasites were selected by the
treatment with XA and MPA. The TgCTPS conditional
mutant was constructed using the Tet-TA system (Meissner,
2001, 2002). In the first step, the TgCTPS ORF including a
C-terminal c-myc tag was cloned into the tetracycline-regulated
expression vector (pNTP3TetO7Sag1) using the NcoI and
PacI restriction sites. The resulting plasmid pNTP3TetO7Sag1-
TgCTPS-c-myc, which is a UPKO-based vector, allowed the
insertion of a tetracycline-regulatable copy of the C-terminally
c-myc-tagged TgCTPS at the TgUPRT locus via double
homologous recombination. The construct was linearized
using ApaI and NcoI restriction enzymes and transfected into
the 1ku80-TaTi strain. Transgenic parasites were selected
with 5µM FUDR followed by isolation of a clonal line by
limited dilution. The tetracycline regulation of TgCTPS-c-
myc was confirmed by IFA, comparing parasites cultured
without anhydrotetracycline (ATc) versus parasites cultured
for 40 h in medium containing 0.5µM ATc. In the second
step, the 5′UTR (1 kb) and 3′UTR (1.2 kb) fragments of the
TgCTPS gene were amplified from gDNA and cloned into the
pTub8CAT vector at the ApaI and XhoI/XbaI sites, respectively,
flanking the chloramphenicol acetyltransferase (CAT) resistance
cassette. The construct was linearized with XbaI and transfected
into the parasites obtained in step one (parasites where the
TgUPRT locus was replaced by TgCTPS-c-myc). Stable parasites
were selected with chloramphenicol as previously described
(Kim et al., 1993) and the appropriate integration of the
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TgCTPS5′UTR-CAT-TgCTPS3′UTR plasmid was verified by
recombination-specific PCR.
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